Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin Added to Cold Storage Solution for Liver Transplant Ischemia/Reperfusion Injury
2017-001581-20Phase 2Completed
- Sponsor
- UPMC ISMETT
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of simvastatin in Liver graft ischemia-reperfusion injury (LIRI), hepatic ischemia-reperfusion injury (HIRI) and ischemia-reperfusion injury (IRI), sponsored by UPMC ISMETT. Primary endpoint: POST-TRANSPLANT LIVER ALLOGRAFT SURVIVAL. Started Jun 2021; status: completed.
02
Drugs
simvastatin
03
Conditions
Liver graft ischemia-reperfusion injury (LIRI)hepatic ischemia-reperfusion injury (HIRI)ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on 2017-001581-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001581-20.